Abstract
Objective: Implantation of a ventricular assist device (VAD) is a seminal therapeutic option for patients with terminal cardiac failure. A growing number of VAD patients are successfully bridged to transplantation, or can even live permanently with the device. However, the success is restricted by frequent severe complications. Haemolysis is a relevant adverse effect of several VAD types, which is the result of destruction of red blood cells, reduced by wall shear stress, flow acceleration and interaction with artificial surfaces. The CH-VAD, a small implantable continuous-flow blood pump, featuring a magnetically levitated impeller and enough hydrodynamic performance, was under development and completed for a 60-days animal implantation experiment in 6 sheep. The goal of this study is to validate the hemolysis of the pump through in vitro and in vivo studies. Methods: A series of in vitro tests was quantified experimentally by using in vitro circulation loop system according to ASTM F1841, the standard practice for the assessment of hemolysis in continuous-flow blood pumps. The hemolysis test in vivo was performed during a 60-days ovine model implantation, which was being conducted under the Institutional Animal Care and Use Committee (IACUC) protocol 05-0600 1. Results in vitro tests showed that the average normalized index of hemolysis (NIH) value of the VAD was 0.007 mg/l. The hemolysis in vivo was evaluated based on the amount of free hemoglobin in the plasma, and which showed that the free hemoglobin level in plasma peaked at 0.95 mg/l on the fifth postoperative day and then returned to an acceptable range of 6.0 mg/dL. Conclusion The magnetic levitation left ventricular assist device has good hemolytic performance. These acceptable performance results supported proceeding initial clinical trail conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A. Worldwide risk factors for heart failure: a systematic review and pooled analysis. Int J Cardiol 2:1186–1194(2013).
Gopalan RS, Arabia FA, Noel P, et al. Hemolysis from aortic regurgitation mimicking pump thrombosis in a patient with a heartMate II left ventricular assist device: a case report[J]. ASAIO J 58(3):278–280(2012).
McLarty A. Mechanical Circulatory Support and the Role of LVADs in Heart Failure Therapy[J]. Clin Med Insights Cardiol 9(Suppl 2):1–5(2015).
Hernandez AF, Grab JD, Gammie JS, et al. A decade of shortterm outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons’ National Cardiac Database. Circulation 116:606–612(2009).
Luckraz H, Woods M, Large SR, et al. And hemolysis goes on: ventricular assist device in combination with veno-venous hemofiltration. Ann Thorac Surg 73(2):546–548(2002).
Nishinaka T, Schima H, Roethy W, et al. The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-to-transplant experience. Circulation 70(11):1421–1425(2006).
Tuzun E, Roberts K, Cohn WE, et al. In vivo evaluation of the HeartWare centrifugal ventricular assist device[J]. Tex Heart Inst J 34:406–411(2007).
Carl A, Johnson Jr, et al. Biocompatibility assessment of the first generation PediaFlow pediatric ventricular assist device. Artif Organs 35(1):9–21(2011).
Vermeulen Windsant IC, de Wit NC, Sertorio JT, et al. Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Critical Care 16(3):R95(2012).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
The authors declare that they have no conflict of interest.
Funding
This study was supported by the National Science Foundation of China (81670371), and the Capital Public Health Project (Z161100000116086).
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Cai, K., Pan, L., Liu, Y., Wu, G., Lin, C. (2019). In Vitro and in Vivo Hemolysis Tests of a Maglev Implantable Ventricular Assist Device. In: Lhotska, L., Sukupova, L., Lacković, I., Ibbott, G. (eds) World Congress on Medical Physics and Biomedical Engineering 2018. IFMBE Proceedings, vol 68/3. Springer, Singapore. https://doi.org/10.1007/978-981-10-9023-3_23
Download citation
DOI: https://doi.org/10.1007/978-981-10-9023-3_23
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-9022-6
Online ISBN: 978-981-10-9023-3
eBook Packages: EngineeringEngineering (R0)